Porton Pharma Solutions Launches State-of-the-Art Small Molecule Platform in Shanghai, Elevating CDMO Services
Porton Pharma Solutions Welcomes Dr. Wenfang Miao as CEO of J-STAR Research, Ushering in a New Era of Pharmaceutical Innovation
Porton Pharma Solutions Welcomes Alexandra Pichard Nielsen, VP of Business Development, at BOS Basel 2023, Driving Innovation and Growth in the Pharmaceutical Industry
Porton Pharma Solutions Expands Global Reach with New Site in Slovenia and Enhanced Manufacturing Capabilities
CfPC Announces Program Of 2021 Pharmaceutical Crystallization Summit(Reproduced)